NCT03285152View on ClinicalTrials.gov

A Study of Ketogenic Diet in Newly Diagnosed Overweight or Obese Endometrial Cancer Patients

NAActive, not recruitingINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

February 19, 2018

Primary Completion Date

August 11, 2026

Study Completion Date

August 11, 2026

Conditions
Endometrial Cancer
Interventions
OTHER

Ketogenic Diet (KD)

specially-formulated very low carbohydrate meals (KD)

OTHER

Standard Diet (SD)

counseling on maintaining adequate nutritional intake from a normal diet (SD)

Trial Locations (8)

10021

New York Weill Cornell Cancer Center at Cornell University, New York

10065

Memorial Sloan Kettering Cancer Center, New York

10604

Memorial Sloan Kettering Westchester (Consent & Follow Up), Harrison

11570

Memorial Sloan Kettering Nassau (Consent and Follow-up), Rockville Centre

11725

Memorial Sloan Kettering Cancer Center @ Commack (Consent and Follow up), Commack

07920

Memorial Sloan Kettering Basking Ridge (Consent and Follow up), Basking Ridge

07748

Memorial Sloan Kettering Monmouth (Consent and follow-up only), Middletown

07645

Memorial Sloan Kettering Bergen (Consent and Follow up), Montvale

All Listed Sponsors
collaborator

Weill Medical College of Cornell University

OTHER

collaborator

New York University

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT03285152 - A Study of Ketogenic Diet in Newly Diagnosed Overweight or Obese Endometrial Cancer Patients | Biotech Hunter | Biotech Hunter